PARANOVUS ENTERTAINMENT TECH (PAVS)

KYG4289N2050 - Common Stock

1.305  -0.01 (-0.76%)

Fundamental Rating

2

Taking everything into account, PAVS scores 2 out of 10 in our fundamental rating. PAVS was compared to 36 industry peers in the Personal Care Products industry. PAVS has a great financial health rating, but its profitability evaluates not so good. PAVS is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

PAVS had negative earnings in the past year.
In the past year PAVS has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: PAVS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: PAVS reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -131.02%, PAVS is doing worse than 94.29% of the companies in the same industry.
Looking at the Return On Equity, with a value of -181.45%, PAVS is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -131.02%
ROE -181.45%
ROIC N/A
ROA(3y)-126.38%
ROA(5y)-72.71%
ROE(3y)-243.05%
ROE(5y)-142.48%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PAVS's Gross Margin of 0.14% is on the low side compared to the rest of the industry. PAVS is outperformed by 91.43% of its industry peers.
In the last couple of years the Gross Margin of PAVS has declined.
PAVS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-82.36%
GM growth 5Y-69.21%

More info and screens

7

2. Health

2.1 Basic Checks

PAVS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PAVS has less shares outstanding
Compared to 5 years ago, PAVS has more shares outstanding
PAVS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 13.20 indicates that PAVS is not in any danger for bankruptcy at the moment.
PAVS's Altman-Z score of 13.20 is amongst the best of the industry. PAVS outperforms 94.29% of its industry peers.
PAVS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.2
ROIC/WACCN/A
WACC7.47%

2.3 Liquidity

PAVS has a Current Ratio of 1.11. This is a normal value and indicates that PAVS is financially healthy and should not expect problems in meeting its short term obligations.
PAVS has a Current ratio of 1.11. This is in the lower half of the industry: PAVS underperforms 71.43% of its industry peers.
A Quick Ratio of 1.11 indicates that PAVS should not have too much problems paying its short term obligations.
PAVS's Quick ratio of 1.11 is in line compared to the rest of the industry. PAVS outperforms 48.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.61% over the past year.
Looking at the last year, PAVS shows a very negative growth in Revenue. The Revenue has decreased by -93.33% in the last year.
Measured over the past years, PAVS shows a very negative growth in Revenue. The Revenue has been decreasing by -36.61% on average per year.
EPS 1Y (TTM)88.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.03%
Revenue 1Y (TTM)-93.33%
Revenue growth 3Y-54.93%
Revenue growth 5Y-36.61%
Sales Q2Q%-99.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PAVS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PAVS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARANOVUS ENTERTAINMENT TECH

NASDAQ:PAVS (12/30/2024, 8:00:02 PM)

1.305

-0.01 (-0.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.07%
Inst Owner Change7.35%
Ins Owners2.06%
Ins Owner ChangeN/A
Market Cap87.88M
Analysts82.86
Price TargetN/A
Short Float %0.3%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.43
P/FCF N/A
P/OCF N/A
P/B 15.75
P/tB 122.72
EV/EBITDA N/A
EPS(TTM)-2.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.1
BVpS0.08
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -131.02%
ROE -181.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.14%
FCFM N/A
ROA(3y)-126.38%
ROA(5y)-72.71%
ROE(3y)-243.05%
ROE(5y)-142.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-82.36%
GM growth 5Y-69.21%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 13.2
F-Score3
WACC7.47%
ROIC/WACCN/A
Cap/Depr(3y)37.17%
Cap/Depr(5y)142.97%
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-93.33%
Revenue growth 3Y-54.93%
Revenue growth 5Y-36.61%
Sales Q2Q%-99.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y95.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.69%
OCF growth 3YN/A
OCF growth 5YN/A